0001829126-22-008372.txt : 20220418
0001829126-22-008372.hdr.sgml : 20220418
20220418215523
ACCESSION NUMBER: 0001829126-22-008372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220414
FILED AS OF DATE: 20220418
DATE AS OF CHANGE: 20220418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PURA VIDA INVESTMENTS, LLC
CENTRAL INDEX KEY: 0001590144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 22833341
BUSINESS ADDRESS:
STREET 1: 512 W 22ND STREET
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10111
BUSINESS PHONE: 646-597-6995
MAIL ADDRESS:
STREET 1: 512 W 22ND STREET
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kamen Efrem
CENTRAL INDEX KEY: 0001789193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 22833340
MAIL ADDRESS:
STREET 1: 512 W 22ND STREET
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncocyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20200213
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4
1
ownership.xml
4
X0306
4
2022-04-14
0
0001642380
Oncocyte Corp
OCX
0001590144
PURA VIDA INVESTMENTS, LLC
512 W 22ND STREET
7TH FLOOR
NEW YORK
NY
10011
0
0
1
0
0001789193
Kamen Efrem
C/O PURA VIDA INVESTMENTS, LLC
888 7TH AVENUE, 6TH FLOOR
NEW YORK
NY
10106
0
0
1
0
Common Stock
2022-04-14
4
P
0
1665898
1.3325
A
7350447
I
By Pura Vida Master Fund, Ltd.
Common Stock
2022-04-14
4
P
0
30790
1.2270
A
7381237
I
By Pura Vida Master Fund, Ltd.
Common Stock
2022-04-14
4
P
0
92370
1.2600
A
7473607
I
By Pura Vida Master Fund, Ltd.
Common Stock
2022-04-14
4
P
0
1916419
1.3325
A
8455823
I
By the Managed Accounts
Common Stock
2022-04-14
4
P
0
19210
1.2270
A
8475033
I
By the Managed Accounts
Common Stock
2022-04-14
4
P
0
57630
1.2600
A
8532663
I
By the Managed Accounts
Common Stock
2022-04-14
4
P
0
767952
1.3325
A
767952
I
By Pura Vida X Fund LP
Common Stock
2022-04-14
4
P
0
1381438
1.3325
A
1381438
I
By the Retirement Trust
Warrant to purchase common stock
1.53
2022-04-14
4
P
0
832949
A
2022-04-19
2027-04-19
Common Stock
832949
832949
I
By Pura Vida Master Fund, Ltd.
Warrant to purchase common stock
1.53
2022-04-14
4
P
0
383976
A
2022-04-19
2027-04-19
Common Stock
383976
383976
I
By Pura Vida X Fund LP
Warrant to purchase common stock
1.53
2022-04-14
4
P
0
690719
A
2022-04-19
2027-04-19
Common Stock
690719
690719
I
By the Retirement Trust
Warrant to purchase common stock
1.53
2022-04-14
4
P
0
958209
A
2022-04-19
2027-04-19
Common Stock
958209
958209
I
By the Managed Accounts
Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325.
Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida X Fund LP (the "Pura Vida X Fund"), Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust"), and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
The Warrants are subject to an ownership blocker provision that prevents the holder from exercising the Warrants if it would beneficially hold more than 19.99% of the common stock following such exercise.
/s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC
2022-04-18
/s/ Efrem Kamen
2022-04-18